QQ客服 官方微博 反馈留言

浏览/检索结果: 共5条，第1-5条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohort 期刊论文 2019, 卷号: 78, 期号: 5, 页码: 648-656 作者:  Wu, Wanlong;  Jordan, Suzana;  Graf, Nicole;  Pena, Janethe de Oliveira;  Curram, John 收藏  |  浏览/下载：25/0  |  提交时间：2020/01/03 Riociguat for the treatment of pulmonary hypertension: Chinese subgroup analyses and comparison 期刊论文 HEART ASIA, 2016, 卷号: 8, 期号: 1 作者:  Wang, Chen;  Jing, Zhi-Cheng;  Huang, Yi-Gao;  Zhou, Da-Xin;  Liu, Zhi-Hong 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/13 Riociguat for the treatment of pulmonary hypertension: Chinese subgroup analyses and comparison 期刊论文 2016, 卷号: 8, 期号: 1, 页码: 74-82 作者:  Wang Chen;  Jing Zhi-Cheng;  Huang Yi-Gao;  Zhou Da-Xin;  Liu Zhi-Hong 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/04 Use of clinically relevant responder threshold criteria to evaluate the response to treatment in the Phase III PATENT-1 study 期刊论文 JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2015, 卷号: 34, 期号: 3 作者:  Langleben, David;  Galie, Nazzareno;  He, Jianguo;  Huang, Yigao;  Humbert, Marc 收藏  |  浏览/下载：9/0  |  提交时间：2019/12/19 pulmonary arterial hypertension  riociguat  soluble guanylate cyclase stimulator  treatment response  responder threshold criteria   Use of clinically relevant responder threshold criteria to evaluate the response to treatment in the Phase III PATENT-1 study 期刊论文 2015, 卷号: 34, 期号: 3, 页码: 338-347 作者:  Langleben, David;  Galie, Nazzareno;  He, Jianguo;  Huang, Yigao;  Humbert, Marc 收藏  |  浏览/下载：5/0  |  提交时间：2020/01/13 pulmonary arterial hypertension  riociguat  soluble guanylate cyclase stimulator  treatment response  responder threshold criteria